Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 2
2009 1
2010 1
2011 1
2012 2
2013 8
2014 5
2015 6
2016 3
2017 4
2018 7
2019 11
2020 16
2021 16
2022 27
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ratio e[au]
Your search for Ramio E[au] retrieved no results
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Zhang X, et al. Among authors: e jy. Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252374 Clinical Trial.
We evaluated the efficacy and safety of perioperative and postoperative S-1 and oxaliplatin (SOX) compared with postoperative capecitabine and oxaliplatin (CapOx) in patients with locally advanced gastric cancer undergoing D2 gastrectomy. ...Patients undergoing D2 gastrect …
We evaluated the efficacy and safety of perioperative and postoperative S-1 and oxaliplatin (SOX) compared with postoperative capecit …
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
Guo K, Zhou L, Shang X, Yang C, E F, Wang Y, Xu M, Wu Y, Li Y, Li M, Yang K, Li X. Guo K, et al. Among authors: e f. Drug Alcohol Depend. 2022 Dec 1;241:109672. doi: 10.1016/j.drugalcdep.2022.109672. Epub 2022 Oct 23. Drug Alcohol Depend. 2022. PMID: 36332593 Review.
Furthermore, compared to the varenicline, evident abstinence superiority was found in varenicline + bupropion (odds ratio = 1.49, 95% confidence interval [1.02, 2.18]). Finally, the surface under the cumulative ranking curve value indicated that varenicline + bupropion has …
Furthermore, compared to the varenicline, evident abstinence superiority was found in varenicline + bupropion (odds ratio = 1.49, 95% …
The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials.
Guo K, Wang S, Shang X, E F, Hou L, Li J, Li Y, Yang K, Li X. Guo K, et al. Among authors: e f. Addict Behav. 2022 Aug;131:107329. doi: 10.1016/j.addbeh.2022.107329. Epub 2022 Apr 5. Addict Behav. 2022. PMID: 35397262 Review.
The NMA showed that, compared to the placebo (PLA), the other six interventions had significant efficacy in smoking cessation, where VAR + BUP showed the best effect of all treatments (odds ratio (OR) = 6.08, 95% confidence interval (CI) [3.47, 10.66]). Moreover, VAR + BUP …
The NMA showed that, compared to the placebo (PLA), the other six interventions had significant efficacy in smoking cessation, where VAR + B …
Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.
Li Z, Shan F, Ying X, Zhang Y, E JY, Wang Y, Ren H, Su X, Ji J. Li Z, et al. Among authors: e jy. JAMA Surg. 2019 Dec 1;154(12):1093-1101. doi: 10.1001/jamasurg.2019.3473. JAMA Surg. 2019. PMID: 31553463 Free PMC article. Clinical Trial.
Patients in the LADG group had better adjuvant chemotherapy completion (adjusted odds ratio, 4.39; 95% CI, 1.63-11.80; P = .003) and were less likely to terminate adjuvant chemotherapy because of adverse effects (10 [22%] vs 21 [42%]; P = .04). ...
Patients in the LADG group had better adjuvant chemotherapy completion (adjusted odds ratio, 4.39; 95% CI, 1.63-11.80; P = .003) and …
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study.
Li C, Wu J, Jiang L, Zhang L, Huang J, Tian Y, Zhao Y, Liu X, Xia L, E H, Gao P, Hou L, Yang M, Ma M, Su C, Zhang H, Chen H, She Y, Xie D, Luo Q, Chen C. Li C, et al. Among authors: e h. Cancer Immunol Immunother. 2023 Mar;72(3):783-794. doi: 10.1007/s00262-022-03262-w. Epub 2022 Sep 3. Cancer Immunol Immunother. 2023. PMID: 36056951
METHODS: In this multi-center retrospective study, 122 and 92 stage I-IIIB NSCLC patients from six hospitals who received neoadjuvant chemoimmunotherapy followed by surgery were included in the discovery and external validation cohort, respectively. Baseline and on-treatment neut …
METHODS: In this multi-center retrospective study, 122 and 92 stage I-IIIB NSCLC patients from six hospitals who received neoadjuvant chemoi …
Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment.
E JY, Li T, McInally L, Thomson K, Shahani U, Gray L, Howe TE, Skelton DA. E JY, et al. Cochrane Database Syst Rev. 2020 Sep 3;9(9):CD009233. doi: 10.1002/14651858.CD009233.pub3. Cochrane Database Syst Rev. 2020. PMID: 32885841 Free PMC article.
Two trials reported the proportion of participants who fell at six months (risk ratio (RR) 0.76, 95% CI 0.38 to 1.51; 28 participants) and 12 months (RR 0.59, 95% CI 0.43 to 0.80, 196 participants) with low-certainty of evidence for each outcome. ...
Two trials reported the proportion of participants who fell at six months (risk ratio (RR) 0.76, 95% CI 0.38 to 1.51; 28 participants …
Long COVID occurrence in COVID-19 survivors.
Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, E B, Ouoba S, Akita T, Tanimine N, Ohdan H, Kubo T, Nagasawa A, Nakanishi T, Takafuta T, Tanaka J. Sugiyama A, et al. Among authors: e b. Sci Rep. 2022 Apr 11;12(1):6039. doi: 10.1038/s41598-022-10051-z. Sci Rep. 2022. PMID: 35411017 Free PMC article.
Multivariate analysis showed that age was an independent risk factor for sequelae (adjusted odds ratios [AOR] for 60 years vs. < 40 years 3.63, p = 0.0165). Possible psychological distress was noted in 30.7% (17.9% of males and 45.0% of females). ...

Multivariate analysis showed that age was an independent risk factor for sequelae (adjusted odds ratios [AOR] for 60 years vs. < 4

…
Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis.
Zhang Z, Cao Y, Tao Y, E M, Tang J, Liu Y, Li F. Zhang Z, et al. Among authors: e m. Diabetes Res Clin Pract. 2020 Jan;159:107990. doi: 10.1016/j.diabres.2019.107990. Epub 2019 Dec 19. Diabetes Res Clin Pract. 2020. PMID: 31866530 Review.
In comparing sulfonylurea users with patients who had not taken sulfonylurea, the pooled risk ratio for developing fracture was 1.14 (95% confifidence interval, 1.08-1.19). In subgroup analyses, the pooled risk ratio of bone fracture in patients receiving sulfonylur …
In comparing sulfonylurea users with patients who had not taken sulfonylurea, the pooled risk ratio for developing fracture was 1.14 …
Optically Controlled Terahertz Dynamic Beam Splitter with Adjustable Split Ratio.
Yin S, Zeng D, Chen Y, Huang W, Zhang C, Zhang W, E Y. Yin S, et al. Among authors: e y. Nanomaterials (Basel). 2022 Mar 31;12(7):1169. doi: 10.3390/nano12071169. Nanomaterials (Basel). 2022. PMID: 35407287 Free PMC article.
The beam splitter is an important functional device due to its ability to steer the propagation of electromagnetic waves. The split-ratio-variable splitter is of significance for optical, terahertz and microwave systems. ...Additionally, we obtain an exponential relationsh …
The beam splitter is an important functional device due to its ability to steer the propagation of electromagnetic waves. The split-ratio …
A meta-analysis of passive smoking and risk of developing Type 2 Diabetes Mellitus.
Wei X, E M, Yu S. Wei X, et al. Among authors: e m. Diabetes Res Clin Pract. 2015 Jan;107(1):9-14. doi: 10.1016/j.diabres.2014.09.019. Epub 2014 Oct 14. Diabetes Res Clin Pract. 2015. PMID: 25488377 Review.
The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies. The odds ratio (ORs) for the association was determined using a fix-effects model. ...
The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies. The odds ratio (ORs) for the association was det …
113 results